Overview of FTY720 Clinical Pharmacokinetics and Pharmacology

The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors

2002 • 1,478 citations

FTY720 Immunosuppression Impairs Effector T Cell Peripheral Homing Without Affecting Induction, Expansion, and Memory

2000 • 364 citations

Sphingosine‐1‐phosphate: signaling inside and out

2000 • 275 citations

Signaling and biological actions of sphingosine 1-phosphate

2003 • 272 citations

FTY720: ALTERED LYMPHOCYTE TRAFFIC RESULTS IN ALLOGRAFT PROTECTION

2001 • 175 citations

Evidence for Edg-3 Receptor-Mediated Activation ofI_K.ACh by Sphingosine-1-Phosphate in Human Atrial Cardiomyocytes

2000 • 85 citations

Sphingolipids and the immune system

2003 • 71 citations

Effects of sphingosine 1-phosphate on pacemaker activity in rabbit sino-atrial node cells

1999 • 70 citations

Sphingolipids as therapeutics

2003 • 69 citations

Oral efficacy of the new immunomodulator FTY720 in cynomolgus monkey kidney allotransplantation, given alone or in combination with cyclosporine or RAD

2002 • 51 citations

ROLE OF CYP4F IN THE METABOLIC CLEARANCE OF FTY720 - PREDICTION OF LOW DRUG TO DRUG INTERACTION POTENTIAL.

2000 • 10 citations